Bristol Myers Squibb to showcase next-generation cancer modalities and leadership across solid tumors at ESMO 2026
BMY•Bristol Myers Squibb said it will showcase next-generation cancer modalities and its leadership across solid tumors at ESMO 2026.
1. ESMO 2026 plans
Bristol Myers Squibb said it will showcase next-generation cancer modalities and its leadership across solid tumors at ESMO 2026.
